Studies indicated that NDAT but not tetrac activated ERK1/2 in K-RAS-wild type colorectal cancer HT-29 cells (Figure 1A), which confirms previous results that NDAT activates ERK1/2 in HT-29 cells (24). Here, KRAS is linked to colorectal cancer.